Evidence map›Paper›PMID 41597515›Full record

ArticleMedicina (Kaunas, Lithuania)2026

Comparison of the Efficacy of Pirfenidone and Nintedanib in the Treatment of Patients with Idiopathic Pulmonary Fibrosis-A Single-Center Experience.

Nikola Trboljevac, Sanja Dimic-Janjic, Milica Kontic, Maja Omcikus, Branislav Ilic, Filip Markovic, Anka Postic, Lidija Isovic, Mihailo Stjepanovic, Dragana Nenezic

Abstract readComparative Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Medicina (Kaunas, Lithuania), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Nikola TrboljevacClinic for Pulmonology, University Clinical Center of Serbia, 11000 Belgrade, Serbia.ORCID 0009-0006-7319-1081
Sanja Dimic-JanjicClinic for Pulmonology, University Clinical Center of Serbia, 11000 Belgrade, Serbia.ORCID 0000-0001-9989-3862
Milica KonticClinic for Pulmonology, University Clinical Center of Serbia, 11000 Belgrade, Serbia.ORCID 0000-0003-1285-3812
Maja OmcikusClinic for Pulmonology, University Clinical Center of Serbia, 11000 Belgrade, Serbia.ORCID 0000-0002-6489-5187
Branislav IlicClinic for Pulmonology, University Clinical Center of Serbia, 11000 Belgrade, Serbia.ORCID 0000-0001-9350-2461
Filip MarkovicClinic for Pulmonology, University Clinical Center of Serbia, 11000 Belgrade, Serbia.ORCID 0000-0001-7992-7279
Anka PosticClinic for Pulmonology, University Clinical Center of Serbia, 11000 Belgrade, Serbia.
Lidija IsovicClinic for Pulmonology, University Clinical Center of Serbia, 11000 Belgrade, Serbia.
Mihailo StjepanovicClinic for Pulmonology, University Clinical Center of Serbia, 11000 Belgrade, Serbia.ORCID 0000-0003-1787-1438
Dragana NenezicClinic for Otorhinolaryngology, University Clinical Center of Serbia, 11000 Belgrade, Serbia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Idiopathic Pulmonary FibrosisIndolesPyridonesAgedCohort StudiesDisease ProgressionFemaleHumansMaleMiddle AgedRetrospective StudiesTreatment OutcomeVital CapacityIndolesnintedanibpirfenidonePyridonesantifibrotic treatment comparisonidiopathic pulmonary fibrosisprogressionreal-world cohortusual interstitial pneumonia

Identifiers

PMID41597515
PMCPMC12844186

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.